Latest Insider Transactions at Corcept Therapeutics Inc (CORT)
This section provides a real-time view of insider transactions for Corcept Therapeutics Inc (CORT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CORCEPT THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CORCEPT THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 10
2024
|
David L Mahoney |
SELL
Payment of exercise price or tax liability
|
Direct |
2,194
-7.31%
|
$50,462
$23.8 P/Share
|
Apr 10
2024
|
David L Mahoney |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
$30,000
$1.74 P/Share
|
Apr 04
2024
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
5,443
-42.67%
|
$141,518
$26.0 P/Share
|
Apr 04
2024
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
5,443
+29.91%
|
$59,873
$11.35 P/Share
|
Apr 01
2024
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
500
-6.4%
|
$13,000
$26.01 P/Share
|
Apr 01
2024
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+6.01%
|
$5,500
$11.35 P/Share
|
Apr 01
2024
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$55,000
$25.3 P/Share
|
Apr 01
2024
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$11,000
$5.86 P/Share
|
Mar 27
2024
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
25,953
-23.34%
|
$648,825
$25.01 P/Share
|
Mar 27
2024
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
25,953
+18.93%
|
$77,859
$3.88 P/Share
|
Mar 19
2024
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+10.5%
|
$20,000
$2.61 P/Share
|
Mar 18
2024
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
17,219
-18.63%
|
$430,475
$25.0 P/Share
|
Mar 18
2024
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
17,219
+15.7%
|
$51,657
$3.88 P/Share
|
Mar 01
2024
|
Joseph Douglas Lyon |
BUY
Grant, award, or other acquisition
|
Direct |
1,014
+6.71%
|
$12,168
$12.03 P/Share
|
Mar 01
2024
|
Joseph Douglas Lyon |
SELL
Payment of exercise price or tax liability
|
Direct |
474
-7.0%
|
$11,376
$24.06 P/Share
|
Mar 01
2024
|
Sean Maduck |
BUY
Grant, award, or other acquisition
|
Direct |
1,272
+0.84%
|
$15,264
$12.03 P/Share
|
Mar 01
2024
|
Sean Maduck |
SELL
Payment of exercise price or tax liability
|
Direct |
505
-0.68%
|
$12,120
$24.06 P/Share
|
Mar 01
2024
|
William Guyer Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
604
-9.09%
|
$14,496
$24.06 P/Share
|
Mar 01
2024
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$50,600
$23.59 P/Share
|
Mar 01
2024
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$11,000
$5.86 P/Share
|
Mar 01
2024
|
Atabak Mokari Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,108
+5.65%
|
$13,296
$12.03 P/Share
|
Mar 01
2024
|
Atabak Mokari Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-5.78%
|
$12,408
$24.06 P/Share
|
Mar 01
2024
|
Gary Charles Robb Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,394
+3.39%
|
$16,728
$12.03 P/Share
|
Mar 01
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
656
-3.37%
|
$15,744
$24.06 P/Share
|
Feb 16
2024
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
1,000
-12.86%
|
$26,000
$26.0 P/Share
|
Feb 16
2024
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+11.4%
|
$11,000
$11.35 P/Share
|
Feb 16
2024
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
27,068
-26.66%
|
$676,700
$25.97 P/Share
|
Feb 16
2024
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
27,068
+12.56%
|
$81,204
$3.59 P/Share
|
Feb 15
2024
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
4,760
-6.01%
|
$119,000
$25.0 P/Share
|
Feb 15
2024
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
4,760
+5.67%
|
$14,280
$3.29 P/Share
|
Feb 01
2024
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$48,400
$22.0 P/Share
|
Feb 01
2024
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$11,000
$5.86 P/Share
|
Jan 08
2024
|
Hazel Hunt Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
29,792
-24.19%
|
$804,384
$27.46 P/Share
|
Jan 08
2024
|
Hazel Hunt Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+28.88%
|
$150,000
$3.02 P/Share
|
Jan 02
2024
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$48,400
$22.11 P/Share
|
Jan 02
2024
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$11,000
$5.86 P/Share
|
Dec 22
2023
|
William Guyer Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,000
-60.09%
|
$320,000
$32.0 P/Share
|
Dec 22
2023
|
William Guyer Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+37.53%
|
$190,000
$19.26 P/Share
|
Dec 15
2023
|
Gary Charles Robb Chief Business Officer |
SELL
Bona fide gift
|
Direct |
750
-3.51%
|
-
|
Dec 13
2023
|
Gary Charles Robb Chief Business Officer |
SELL
Other acquisition or disposition
|
Indirect |
1,000
-11.49%
|
-
|
Dec 08
2023
|
Gary Charles Robb Chief Business Officer |
BUY
Bona fide gift
|
Indirect |
1,917
+6.84%
|
-
|
Dec 06
2023
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
6,212
-22.51%
|
$167,724
$27.01 P/Share
|
Dec 05
2023
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,381
-4.76%
|
$35,906
$26.27 P/Share
|
Dec 04
2023
|
Gary Charles Robb Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,788
-23.27%
|
$228,488
$26.26 P/Share
|
Dec 04
2023
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+28.42%
|
$45,000
$3.29 P/Share
|
Dec 04
2023
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
2,432
-29.35%
|
$63,232
$26.0 P/Share
|
Dec 04
2023
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
2,432
+22.69%
|
$26,752
$11.35 P/Share
|
Dec 01
2023
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$55,000
$25.47 P/Share
|
Dec 01
2023
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$11,000
$5.86 P/Share
|
Dec 01
2023
|
William Guyer Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,218
+8.78%
|
$14,616
$12.99 P/Share
|